• 9220 Citations
  • 35 h-Index
20052020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Review article
2020

Autoimmunity, checkpoint inhibitor therapy and immune-related adverse events: A review

Khan, S. & Gerber, D. E., Aug 2020, In : Seminars in Cancer Biology. 64, p. 93-101 9 p.

Research output: Contribution to journalReview article

9 Scopus citations
2019

Hyperprogressive disease: A distinct effect of immunotherapy?

Popat, V. & Gerber, D. E., 2019, In : Journal of Thoracic Disease. 11, p. S262-S265

Research output: Contribution to journalReview article

4 Scopus citations

Immunotherapy for non-small cell lung cancer: From clinical trials to real-world practice

Rashdan, S. & Gerber, D. E., Jun 1 2019, In : Translational Lung Cancer Research. 8, 3, p. 202-207 6 p.

Research output: Contribution to journalReview article

1 Scopus citations

Newer-generation EGFR inhibitors in lung cancer: How are they best used?

Le, T. & Gerber, D. E., Mar 2019, In : Cancers. 11, 3, 366.

Research output: Contribution to journalReview article

Open Access
13 Scopus citations
2017

ALK alterations and inhibition in lung cancer

Le, T. & Gerber, D. E., Feb 1 2017, In : Seminars in Cancer Biology. 42, p. 81-88 8 p.

Research output: Contribution to journalReview article

14 Scopus citations

Institutional scientific review of cancer clinical research protocols: A unique requirement that affects activation timelines

Ning, N., Yan, J., Dietrich, M. F., Xie, X. J. & Gerber, D. E., Dec 1 2017, In : Journal of Oncology Practice. 13, 12, p. e982-e991

Research output: Contribution to journalReview article

2016

Small cell lung cancer: Can recent advances in biology and molecular biology be translated into improved outcomes?

Bunn, P. A., Minna, J. D., Augustyn, A., Gazdar, A. F., Ouadah, Y., Krasnow, M. A., Berns, A., Brambilla, E., Rekhtman, N., Massion, P. P., Niederst, M., Peifer, M., Yokota, J., Govindan, R., Poirier, J. T., Byers, L. A., Wynes, M. W., McFadden, D. G., MacPherson, D., Hann, C. L. & 34 others, Farago, A. F., Dive, C., Teicher, B. A., Peacock, C. D., Johnson, J. E., Cobb, M. H., Wendel, H. G., Spigel, D., Sage, J., Yang, P., Pietanza, M. C., Krug, L. M., Heymach, J., Ujhazy, P., Zhou, C., Goto, K., Dowlati, A., Christensen, C. L., Park, K., Einhorn, L. H., Edelman, M. J., Giaccone, G., Gerber, D. E., Salgia, R., Owonikoko, T., Malik, S., Karachaliou, N., Gandara, D. R., Slotman, B. J., Blackhall, F., Goss, G., Thomas, R., Rudin, C. M. & Hirsch, F. R., 2016, In : Journal of Thoracic Oncology. 11, 4, p. 453-474 22 p.

Research output: Contribution to journalReview article

85 Scopus citations
2015

Alchemist trials: A golden opportunity to transform outcomes in early-stage non-small cell lung cancer

Govindan, R., Mandrekar, S. J., Gerber, D. E., Oxnard, G. R., Dahlberg, S. E., Chaft, J., Malik, S., Mooney, M., Abrams, J. S., Jänne, P. A., Gandara, D. R., Ramalingam, S. S. & Vokes, E. E., Dec 15 2015, In : Clinical Cancer Research. 21, 24, p. 5439-5444 6 p.

Research output: Contribution to journalReview article

47 Scopus citations
9 Scopus citations

Concurrent pemetrexed and radiation therapy in the treatment of patients with inoperable stage III non-small cell lung cancer: A systematic review of completed and ongoing studies

Choy, H., Gerber, D. E., Bradley, J. D., Iyengar, P., Monberg, M., Treat, J., Govindan, R., Koustensis, A., Barker, S. & Obasaju, C., Mar 1 2015, In : Lung Cancer. 87, 3, p. 232-240 9 p.

Research output: Contribution to journalReview article

15 Scopus citations
2013

Locally advanced lung cancer: An optimal setting for vaccines and other immunotherapies

Iyengar, P. & Gerber, D. E., May 1 2013, In : Cancer Journal (United States). 19, 3, p. 247-262 16 p.

Research output: Contribution to journalReview article

11 Scopus citations

Maintenance Chemotherapy for Advanced Non-Small-Cell Lung Cancer: New Life for an Old Idea

Gerber, D. E. & Schiller, J. H., Mar 10 2013, In : Journal of Clinical Oncology. 31, 8, p. 1009-1020 12 p.

Research output: Contribution to journalReview article

92 Scopus citations
2012

Targeting the PI3K pathway for cancer therapy

Sadeghi, N. & Gerber, D. E., Jun 2012, In : Future Medicinal Chemistry. 4, 9, p. 1153-1169 17 p.

Research output: Contribution to journalReview article

28 Scopus citations
2011

Targeted therapies for lung cancer: Clinical experience and novel agents

Larsen, J. E., Cascone, T., Gerber, D. E., Heymach, J. V. & Minna, J. D., Nov 1 2011, In : Cancer Journal. 17, 6, p. 512-527 16 p.

Research output: Contribution to journalReview article

77 Scopus citations
2010

ALK Inhibition for Non-Small Cell Lung Cancer: From Discovery to Therapy in Record Time

Gerber, D. E. & Minna, J. D., Dec 14 2010, In : Cancer Cell. 18, 6, p. 548-551 4 p.

Research output: Contribution to journalReview article

177 Scopus citations

Cetuximab in combination therapy: From bench to clinic

Gerber, D. E. & Choy, H., Mar 1 2010, In : Cancer and Metastasis Reviews. 29, 1, p. 171-180 10 p.

Research output: Contribution to journalReview article

22 Scopus citations

Paraneoplastic syndromes: An approach to diagnosis and treatment

Pelosof, L. C. & Gerber, D. E., Sep 2010, In : Mayo Clinic Proceedings. 85, 9, p. 838-854 17 p.

Research output: Contribution to journalReview article

288 Scopus citations
2008

EGFR inhibition in the treatment of non-small cell lung cancer

Gerber, D. E., Sep 1 2008, In : Drug Development Research. 69, 6, p. 359-372 14 p.

Research output: Contribution to journalReview article

27 Scopus citations

Recent advances in radiation therapy

Gerber, D. E. & Chan, T. A., Dec 1 2008, In : American Family Physician. 78, 11, p. 1254-1262+1263-1264

Research output: Contribution to journalReview article

17 Scopus citations

Targeted therapies: A new generation of cancer treatments

Gerber, D. E., Feb 1 2008, In : American Family Physician. 77, 3, p. 311-319 9 p.

Research output: Contribution to journalReview article

261 Scopus citations
2007

Emerging monoclonal antibody therapies for malignant gliomas

Gerber, D. E. & Laterra, J., Apr 1 2007, In : Expert Opinion on Investigational Drugs. 16, 4, p. 477-494 18 p.

Research output: Contribution to journalReview article

14 Scopus citations

The impact of thrombocytopenia from temozolomide and radiation in newly diagnosed adults with high-grade gliomas

Gerber, D. E., Grossman, S. A., Zeltzman, M., Parisi, M. A. & Kleinberg, L., Jan 1 2007, In : Neuro-oncology. 9, 1, p. 47-52 6 p.

Research output: Contribution to journalReview article

71 Scopus citations

Venous thromboembolism occurs infrequently in meningioma patients receiving combined modality prophylaxis

Gerber, D. E., Segal, J. B., Salhotra, A., Olivi, A., Grossman, S. A. & Streiff, M. B., Jan 15 2007, In : Cancer. 109, 2, p. 300-305 6 p.

Research output: Contribution to journalReview article

20 Scopus citations
2006

Management of venous thromboembolism in patients with primary and metastatic brain tumors

Gerber, D. E., Grossman, S. A. & Streiff, M. B., Mar 10 2006, In : Journal of Clinical Oncology. 24, 8, p. 1310-1318 9 p.

Research output: Contribution to journalReview article

110 Scopus citations